Showing results (221-230 of 256) with videos related to

Sort By:
Pageof 26
Leukemia|February 1, 2020
Daratumumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: extended follow-up of POLLUX, a randomized, open-label, phase 3 studyNizar J Bahlis, Meletios A Dimopoulos, Darrell J White, et al.
Oncoimmunology|April 11, 2018
A blood dendritic cell vaccine for acute myeloid leukemia expands anti-tumor T cell responses at remissionJennifer L Hsu, Christian E Bryant, Michael S Papadimitrious, et al.
Science (New York, N.Y.)|December 17, 2016
Extensive water ice within Ceres' aqueously altered regolith: Evidence from nuclear spectroscopyT H Prettyman, N Yamashita, M J Toplis, et al.
JAMA Oncology|January 7, 2021
Frequency of and Factors Associated With Nonmedical Opioid Use Behavior Among Patients With Cancer Receiving Opioids for Cancer PainSriram Yennurajalingam, Joseph Arthur, Suresh Reddy, et al.
Blood Advances|September 28, 2020
Inverse relationship between oligoclonal expanded CD69- TTE and CD69+ TTE cells in bone marrow of multiple myeloma patientsSlavica Vuckovic, Christian E Bryant, Ka Hei Aleks Lau, et al.
The Lancet. Haematology|July 18, 2025
Patient-reported outcomes with belantamab mafodotin, bortezomib, and dexamethasone versus daratumumab, bortezomib, and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): results from a phase 3, open-label, randomised controlled trialVania Hungria, Marek Hus, ChengCheng Fu, et al.
The Lancet. Haematology|February 13, 2025
Long-term efficacy and safety of luspatercept for the treatment of anaemia in patients with transfusion-dependent β-thalassaemia (BELIEVE): final results from a phase 3 randomised trialMaria Domenica Cappellini, Vip Viprakasit, Pencho Georgiev, et al.
Science Advances|March 17, 2018
Variations in the amount of water ice on Ceres' surface suggest a seasonal water cycleAndrea Raponi, Maria Cristina De Sanctis, Alessandro Frigeri, et al.
Hypertension (Dallas, Tex. : 1979)|December 16, 2020
Association Between Blood Pressure Control and Coronavirus Disease 2019 Outcomes in 45 418 Symptomatic Patients With Hypertension: An Observational Cohort StudyJames P Sheppard, Brian D Nicholson, Joseph Lee, et al.
Blood|February 17, 2026
Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphomaMark R Dowling, Edward Robert Scheffer Cliff, Anthony Jeffrey, et al.
Pageof 26